A common diabetes drug can be repurposed to help overweight and obese people with knee arthritis, a new study says. Metformin reduced knee arthritis pain during a six-month treatment period, potentially delaying the need for knee replacement surgery, researchers reported recently in the Journal of the American Medical Association. “Metformin works in a number of ways on the knee, including affecting low-grade inflammation and other metabolic pathways that are important in knee osteoarthritis,” senior researcher Flavia Cicuttini, a professor of health systems services and policy at Monash University in Australia, said in a news release. “It is a different way to treat knee osteoarthritis pain.” Metformin is commonly prescribed to help lower blood sugar levels in people with type 2 diabetes. It reduces sugar absorption from the intestines, lowers glucose production in the liver, and improves insulin sensitivity, according to Drugs.com. For this study, researchers recruited 107 overweight or obese people with knee pain and randomly assigned about half to take metformin pills and the rest a placebo. The metformin group reported a 31-point reduction in pain after six months, compared with a 19-point reduction for the placebo group. The results show that metformin is a potentially new and affordable way to improve knee pain from arthritis, Cicuttini said. Today, people are asked to exercise and lose weight to reduce knee pain, which many find… read on > read on >

















